{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:06:17Z","timestamp":1790867177060,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"International AIDS Society Mark Wainberg Fellowship Program (IAS-MWF), supported by ViiV Healthcare under a signed agreement"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20658-7","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:30:26Z","timestamp":1761039026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence and predictors of mortality among persons with rifampicin-resistant tuberculosis and HIV in Mozambique"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-9609","authenticated-orcid":false,"given":"Edy","family":"Nacarapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedita","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Munyangaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"Os\u00f3rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Manuel","family":"Ramos-Rincon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"20658_CR1","unstructured":"The National Institute for Communicable Diseases (NICD). Updated-RR-TB-Clinical-Guidelines-September-2023, South African National Department of Health. [Online]. Available: https:\/\/www.health.gov.za\/wp-content\/uploads\/2023\/10\/Updated-RR-TB-Clinical-Guidelines-September-2023.pdf (2024)."},{"key":"20658_CR2","unstructured":"Global Tuberculosis Programme (GTB). Global tuberculosis report 2023, World Health Organization (WHO). [Online]. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240083851 (2024)."},{"key":"20658_CR3","unstructured":"WHO, The End, T. B., Strategy & World Health Organization (WHO). [Online]. Available: https:\/\/www.who.int\/tb\/End_TB_brochure.pdf (2022)."},{"key":"20658_CR4","unstructured":"WHO. Implementing the End TB Strategy, World Health Organization (WHO). [Online]. Available: https:\/\/www.who.int\/westernpacific\/activities\/implementing-the-end-tb-strategy (2022)."},{"key":"20658_CR5","doi-asserted-by":"publisher","unstructured":"Wakjira, M. K., Sandy, P. T. & Mavhandu-Mudzusi, A. H. Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia. PLoS One. 17 (2), e0262318. https:\/\/doi.org\/10.1371\/journal.pone.0262318 (Feb. 2022).","DOI":"10.1371\/journal.pone.0262318"},{"key":"20658_CR6","unstructured":"Governo do Distrito de Ch\u00f3kw\u00e8. Localizacao geogr\u00e1fica - Governo do Distrito de Ch\u00f3kw\u00e8, Governo do Distrito de Ch\u00f3kw\u00e8. [Online]. Available: https:\/\/www.gaza.gov.mz\/por\/Ver-Meu-Distrito\/Chokwe\/O-Distrito\/Localizacao-Geografica (2023)."},{"key":"20658_CR7","doi-asserted-by":"publisher","unstructured":"Moon, T. D. et al. Tuberculosis treatment outcomes among children in rural Southern mozambique: A 12-Year retrospective study, https:\/\/doi.org\/10.1097\/INF.0000000000002435","DOI":"10.1097\/INF.0000000000002435"},{"key":"20658_CR8","doi-asserted-by":"publisher","unstructured":"Nacarapa, E. et al. Effect of Xpert MTB\/RIF testing introduction and favorable outcome predictors for tuberculosis treatment among HIV infected adults in rural Southern Mozambique. A retrospective cohort study. PLOS ONE 15(3), e0229995 https:\/\/doi.org\/10.1371\/journal.pone.0229995 (2020).","DOI":"10.1371\/journal.pone.0229995"},{"key":"20658_CR9","doi-asserted-by":"publisher","unstructured":"Nacarapa, E. et al. Extrapulmonary tuberculosis mortality according to clinical and point of care ultrasound features in Mozambique. Sci. Rep. 12 (1), 16675. https:\/\/doi.org\/10.1038\/s41598-022-21153-z (Oct. 2022).","DOI":"10.1038\/s41598-022-21153-z"},{"key":"20658_CR10","unstructured":"S. V. de P. Daughters of Charity, Hospital Carmelo de Ch\u00f3kw\u00e8, Stop TB Parternship. [Online]. Available: https:\/\/stoptb.org\/partners\/partner_profile2.asp?PID=70107"},{"key":"20658_CR11","unstructured":"MISAU PNCT (Programa Nacional de Controlo da Tuberculose. ), Manual de Manejo Cl\u00ednico e Program\u00e1tico da Tuberculose Multirresistente, Minist\u00e9rio da Sa\u00fade de Mo\u00e7ambique, (2019)."},{"key":"20658_CR12","doi-asserted-by":"publisher","unstructured":"O\u2019Donnell, C., Sanchez, P. A., Celestin, B., McConnell, M. V. & Haddad, F. The Echocardiographic Evaluation of the Right Heart: Current and Future Advances., Curr Cardiol Rep 25(12), 1883\u20131896. https:\/\/doi.org\/10.1007\/s11886-023-02001-6 (2023).","DOI":"10.1007\/s11886-023-02001-6"},{"key":"20658_CR13","doi-asserted-by":"publisher","unstructured":"Arrigo, M. et al. Mar., Diagnosis and treatment of right ventricular failure secondary to acutely increased right ventricular afterload (acute cor pulmonale): a clinical consensus statement of the Association for Acute CardioVascular Care of the European Society of Cardiology., Eur Heart J Acute Cardiovasc Care 13(3), 304\u2013312, https:\/\/doi.org\/10.1093\/ehjacc\/zuad157 (2024).","DOI":"10.1093\/ehjacc\/zuad157"},{"key":"20658_CR14","unstructured":"Cambaza, E. Estudo Dos n\u00edveis De Hemoglobina E preval\u00eancia De Anemia Em Adultos (da Cidade de Maputo, 2013)."},{"key":"20658_CR15","unstructured":"WHO. Guideline on Haemoglobin Cutoffs To Define Anaemia in Individuals and Populations (World Health Organization (WHO), 2024)."},{"key":"20658_CR16","unstructured":"Collins, A. How old will each generation be in 2025? Newsweek. [Online]. Available: https:\/\/www.newsweek.com\/how-old-will-each-generation-2025-2016059 (2025)."},{"key":"20658_CR17","unstructured":"Research, N. United States population by age, Neilsberg. [Online]. Available: https:\/\/www.neilsberg.com\/insights\/united-states-population-by-age\/ (2025)."},{"key":"20658_CR18","doi-asserted-by":"publisher","first-page":"e8365","DOI":"10.7717\/peerj.8365","volume":"8","author":"Y Peng","year":"2020","unstructured":"Peng, Y., Zhu, Q., Wang, B. & Ren, J. A cross-sectional study on interference control: age affects reactive control but not proactive control. PeerJ 8, e8365 (2020).","journal-title":"PeerJ"},{"key":"20658_CR19","unstructured":"Guideline for good clinical practice - ICH. [Online]. Available: https:\/\/database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"key":"20658_CR20","unstructured":"Guideline for good clinical practice, (1997)."},{"key":"20658_CR21","unstructured":"Global Programme on Tuberculosis and Lung Health (GTB). WHO consolidated guidelines on tuberculosis. Module 4: treatment-drug-resistant tuberculosis treatment, 2022 update. World Health Organization (WHO), 2022. [Online]. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240088542 (2025)."},{"key":"20658_CR22","doi-asserted-by":"publisher","unstructured":"Silva, C. I. S. & M\u00fcller, N. L. Fibrothorax: online case 78, in The Teaching Files: Chest, Elsevier, e156\u2013e157. doi: https:\/\/doi.org\/10.1016\/B978-1-4160-6110-6.10833-9. (2010).","DOI":"10.1016\/B978-1-4160-6110-6.10833-9"},{"key":"20658_CR23","doi-asserted-by":"publisher","unstructured":"Subotic, D. et al. Surgery and pleuro-pulmonary tuberculosis: a scientific literature review. J. Thorac. Dis. 8 (7), E474\u2013E485. https:\/\/doi.org\/10.21037\/jtd.2016.05.59 (Jul. 2016).","DOI":"10.21037\/jtd.2016.05.59"},{"key":"20658_CR24","doi-asserted-by":"publisher","unstructured":"Quenard, F., Fournier, P. E., Drancourt, M. & Brouqui, P. Role of second-line injectable antituberculosis drugs in the treatment of MDR\/XDR tuberculosis. Int. J. Antimicrob. Agents. 50 (2), 252\u2013254. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.01.042 (Aug. 2017).","DOI":"10.1016\/j.ijantimicag.2017.01.042"},{"key":"20658_CR25","unstructured":"MISAU PNC ITS-HIV\/SIDA Programa Nacional de Controle de ITS-HIV\/SIDA - Directrizes nacionais, Minist\u00e9rio da Sa\u00fade de Mo\u00e7ambique [Online]. Available: https:\/\/www.misau.gov.mz\/index.php\/hiv-sida-directrizes-nacionais (2022)."},{"key":"20658_CR26","doi-asserted-by":"publisher","unstructured":"Nacarapa, E. et al. Predictors of attrition among adults in a rural HIV clinic in Southern mozambique: 18-year retrospective study. Sci. Rep. 11 (1), 17897. https:\/\/doi.org\/10.1038\/s41598-021-97466-2 (Dec. 2021).","DOI":"10.1038\/s41598-021-97466-2"},{"key":"20658_CR27","doi-asserted-by":"publisher","unstructured":"Yang, X. et al. Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders., J. Leukoc. Biol. 107(4), 597\u2013612, https:\/\/doi.org\/10.1002\/JLB.4MR1019-189R (2020).","DOI":"10.1002\/JLB.4MR1019-189R"},{"key":"20658_CR28","unstructured":"ASHM Developing a sustainable HIV. Immunological failure: persistent CD4\u2009+\u2009T cell deficiency. [Online]. Available: https:\/\/hivmanagement.ashm.org.au\/long-term-management-of-antiretroviral-therapy\/immunological-failure-persistent-cd4-t-cell-deficiency\/ (2022)."},{"key":"20658_CR29","unstructured":"WHO. HIV prevention, infant diagnosis, antiretroviral initiation and monitoring guidelines, (2021)."},{"key":"20658_CR30","unstructured":"MISAU PNC ITS-HIV\/SIDA Gui\u00e3o de manejo do paciente com doen\u00e7a avan\u00e7ada por HIV \u2013\u20092022, Minist\u00e9rio da Sa\u00fade de Mo\u00e7ambique. [Online]. Available: https:\/\/www.misau.gov.mz\/index.php\/guioes-de-prevencao-e-de-cuidados-e-tratamento?download=1352:guiao-de-manejo-do-paciente-com-doenca-avancada-por-hiv-2022 (2023)."},{"key":"20658_CR31","unstructured":"MISAU PNC ITS-HIV\/SIDA Normas Clinicas Actualizadas para o seguimento do paciente HIV Positivo, Comite TARV Mozambique. [Online]. Available: https:\/\/comitetarvmisau.co.mz\/docs\/orientacoes_nacionais\/Circular_Normas_Cl%C3%ADnicas_Actualizadas_29_11_19.pdf (2023)."},{"key":"20658_CR32","doi-asserted-by":"publisher","unstructured":"Chun, H. M. et al. Reaching HIV epidemic control in Nigeria using a lower HIV viral load suppression cut-off. AIDS 37(13), 2081\u20132085, https:\/\/doi.org\/10.1097\/QAD.0000000000003672 (2023).","DOI":"10.1097\/QAD.0000000000003672"},{"key":"20658_CR33","doi-asserted-by":"publisher","unstructured":"Bavinton, B. R. & Rodger, A. J. Undetectable viral load and HIV transmission dynamics on an individual and population level: where next in the global HIV response? Curr. Opin. Infect. Dis. 33(1), 20\u201327, https:\/\/doi.org\/10.1097\/QCO.0000000000000613 (2020).","DOI":"10.1097\/QCO.0000000000000613"},{"key":"20658_CR34","unstructured":"HIV.gov, Viral Suppression and an Undetectable Viral Load, HIV.gov. [Online]. Available: https:\/\/www.hiv.gov\/hiv-basics\/staying-in-hiv-care\/hiv-treatment\/viral-suppression (2025)."},{"key":"20658_CR35","doi-asserted-by":"publisher","unstructured":"Handoko, R. et al. Determinants of suboptimal CD4 + T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV-1 infection. J. Int. AIDS Soc. 23 (9). https:\/\/doi.org\/10.1002\/jia2.25585 (2020).","DOI":"10.1002\/jia2.25585"},{"issue":"10","key":"20658_CR36","doi-asserted-by":"publisher","first-page":"e0205601","DOI":"10.1371\/journal.pone.0205601","volume":"13","author":"M Verdecchia","year":"2018","unstructured":"Verdecchia, M. et al. Model of care and risk factors for poor outcomes in patients on multi-drug resistant tuberculosis treatment at two facilities in eSwatini (formerly Swaziland), 2011\u20132013. PLoS One. 13 (10), e0205601. https:\/\/doi.org\/10.1371\/journal.pone.0205601 (2018).","journal-title":"PLoS One"},{"key":"20658_CR37","doi-asserted-by":"publisher","unstructured":"Padayatchi, N., Abdool Karim, S. S., Naidoo, K., Grobler, A. & Friedland, G. Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial. Int. J. Tuberc. Lung. Dis. 18(2), 147\u201354, https:\/\/doi.org\/10.5588\/ijtld.13.0627 (2014).","DOI":"10.5588\/ijtld.13.0627"},{"key":"20658_CR38","doi-asserted-by":"publisher","unstructured":"Summers, N. A. & Armstrong, W. S. Management of Advanced HIV Disease., Infect. Dis. Clin. North Am. 33(3), 743\u2013767, https:\/\/doi.org\/10.1016\/j.idc.2019.05.005 (2019).","DOI":"10.1016\/j.idc.2019.05.005"},{"key":"20658_CR39","doi-asserted-by":"publisher","unstructured":"Singh, K. P. et al. Clinical standards for the management of adverse effects during treatment for TB, The International Journal of Tuberculosis and Lung Disease 27(7), 506\u2013519, https:\/\/doi.org\/10.5588\/ijtld.23.0078 (2023).","DOI":"10.5588\/ijtld.23.0078"},{"key":"20658_CR40","unstructured":"MISAU PNCT (Programa Nacional de Combate a Tuberculose. Manuais de Directrizes e Gui\u00f5es de TB, Minist\u00e9rio da Sa\u00fade de Mo\u00e7ambique. [Online]. Available: https:\/\/www.misau.gov.mz\/index.php\/manuais-directrizes-e-guioes-tb (2022)."},{"key":"20658_CR41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13690-020-00448-5","volume":"78","author":"DB Ketema","year":"2020","unstructured":"Ketema, D. B., Alene, M., Assemie, M. A., Yismaw, L. & Merid, M. W. Risk factors for mortality among drug-resistant tuberculosis patients registered for drug-resistant treatment in Amhara region, ethiopia: a historical cohort study. Arch. Public. Health. 78, 69. https:\/\/doi.org\/10.1186\/s13690-020-00448-5 (2020).","journal-title":"Arch. Public. Health"},{"key":"20658_CR42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27746","author":"T Dasaradhan","year":"2022","unstructured":"Dasaradhan, T. et al. Tuberculosis-Associated anemia: A narrative review. Cureus Aug. https:\/\/doi.org\/10.7759\/cureus.27746 (2022).","journal-title":"Cureus Aug"},{"key":"20658_CR43","doi-asserted-by":"publisher","unstructured":"Hella, J. et al. Anemia in tuberculosis cases and household controls from tanzania: contribution of disease, coinfections, and the role of Hepcidin. PLoS One. 13 (4), e0195985. https:\/\/doi.org\/10.1371\/journal.pone.0195985 (2018).","DOI":"10.1371\/journal.pone.0195985"},{"key":"20658_CR44","doi-asserted-by":"publisher","unstructured":"Singh, L., Mathibe, L. J. & Bangalee, V. The efficacy of bedaquiline versus Kanamycin in multi-drug resistant tuberculosis: A systematic scoping review. Health SA Gesondheid. 26 https:\/\/doi.org\/10.4102\/hsag.v26i0.1708 (2021).","DOI":"10.4102\/hsag.v26i0.1708"},{"key":"20658_CR45","unstructured":"Merle, C., Fund, G., WHO. The ShORRT initiative in the Africa region: spotlight on Mozambique. World Health Organization (WHO). [Online]. Available: https:\/\/tdr.who.int\/newsroom\/news\/item\/02-02-2022-the-shorrt-initiative-in-the-africa-region-spotlight-on-mozambique (2024)."},{"key":"20658_CR46","unstructured":"Souleymane, M. B., Decroo, T., Soumana, A. & Piubello, A. OA06-241-15 Linezolid-containing short treatment regimens result in high risk of severe adverse events, in The Union Conference 2023, Paris: The Union - International Union Against Tuberculosis and Lung Disease. Accessed: Aug. 13, 2024. [Online]. Available: https:\/\/conf2023.theunion.org\/wp-content\/uploads\/2023\/12\/UNION2023_Abstracts.pdf (2023)."},{"key":"20658_CR47","doi-asserted-by":"publisher","unstructured":"Yadav, S. Pulmonary tuberculosis with concomitant Aspergillus fungal ball in a diabetic Indian male: A rare case report. Cureus 15 (7), e41443. https:\/\/doi.org\/10.7759\/cureus.41443 (Jul. 2023).","DOI":"10.7759\/cureus.41443"},{"key":"20658_CR48","doi-asserted-by":"publisher","unstructured":"Rachow, A. et al. Aug., Performance of spirometry assessment at TB diagnosis., Int. J. Tuberc. Lung Dis. 27(11), 850\u2013857, https:\/\/doi.org\/10.5588\/ijtld.23.0040  (2023).","DOI":"10.5588\/ijtld.23.0040"},{"key":"20658_CR49","doi-asserted-by":"publisher","unstructured":"van Heerden, J. K., Louw, E. H., Thienemann, F., Engel, M. E. & Allwood, B. W. The prevalence of pulmonary hypertension in post-tuberculosis and active tuberculosis populations: a systematic review and meta-analysis. Eur. Respir Rev. 33 (171). https:\/\/doi.org\/10.1183\/16000617.0154-2023 (2024).","DOI":"10.1183\/16000617.0154-2023"},{"key":"20658_CR50","doi-asserted-by":"publisher","unstructured":"Sanders, J. L., Koestenberger, M., Rosenkranz, S. & Maron, B. A. Right ventricular dysfunction and long-term risk of death. Cardiovasc. Diagn. Ther. 10(5), 1646\u20131658, https:\/\/doi.org\/10.21037\/cdt-20-450 (2020).","DOI":"10.21037\/cdt-20-450"},{"key":"20658_CR51","doi-asserted-by":"publisher","unstructured":"Rosenkranz, S., Howard, L. S., Gomberg-Maitland, M. & Hoeper, M. M. Systemic consequences of pulmonary hypertension and Right-Sided heart failure. Circulation 141 (8), 678\u2013693. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022362 (2020).","DOI":"10.1161\/CIRCULATIONAHA.116.022362"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20658-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20658-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20658-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:01:45Z","timestamp":1761084105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20658-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20658"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20658-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5173422\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical clearance was obtained from the Institutional Bioethics Committee for Health of Gaza\n                      (IRB0002657 \u2013 Comit\u00e9 Institucional de Bio\u00e9tica para a Sa\u00fade de Gaza\n                      ,\n                      19\/CIBS-Gaza\/2021\n                      and permission to perform the study was also obtained from the Gaza Health Directorate\n                      (Direc\u00e7\u00e3o Provincial de Sa\u00fade de Gaza\n                      ,\n                      DPS-Gaza\/30-04-2019).\n                      This study received a Research Determination from the University Miguel Hernandez de Elche-Spain under the authorization code COIR\n                      (Solicitud C\u00f3digo de Investigaci\u00f3n Responsable [COIR]: ADH.SPU.JMRR.EEA.23).\n                      The need for written informed consent to participate in the study and for its publication was explicitly waived by IRB0002657 (\n                      Comit\u00e9 Institucional de Bio\u00e9tica para a Sa\u00fade de Gaza\n                      ,\n                      19\/CIBS-Gaza\/2021)\n                      . All information obtained during the study was kept confidential. Analysis was performed on de-identified aggregated data. Furthermore, this study was conducted in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"We performed analysis on routine administrative data; consent for publication is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"36748"}}